Cargando...
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
Androgen receptor (AR) signaling is a critical pathway for prostate cancer cells, and androgen-deprivation therapy (ADT) remains the principal treatment for patients with locally advanced and metastatic disease. However, over time, most tumors become resistant to ADT. The view of castration-resistan...
Guardado en:
| Publicado en: | Oncogene |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333106/ https://ncbi.nlm.nih.gov/pubmed/24837363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.115 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|